Package 76420-812-60

{"route": ["ORAL"], "spl_id": "2dffd9ed-8b4a-a56b-e063-6394a90ae043", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["637e89e5-8f6e-4392-8045-a778cb9ed138"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-01)", "package_ndc": "76420-812-01", "marketing_start_date": "20240507"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-05)", "package_ndc": "76420-812-05", "marketing_start_date": "20240507"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-30)", "package_ndc": "76420-812-30", "marketing_start_date": "20240507"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-60)", "package_ndc": "76420-812-60", "marketing_start_date": "20240507"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-90)", "package_ndc": "76420-812-90", "marketing_start_date": "20240507"}], "brand_name": "Bupropion Hydrochloride", "product_id": "76420-812_2dffd9ed-8b4a-a56b-e063-6394a90ae043", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "76420-812", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA077285", "marketing_category": "ANDA", "marketing_start_date": "20150217", "listing_expiration_date": "20261231"}